 Connection
Elizabeth Bayliss to Polypharmacy
This is a "connection" page, showing publications Elizabeth Bayliss has written about Polypharmacy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.760 |
|
|
|
-
Bayliss EA, Powers JD, Weffald LA, Rasmussen JR, Pieper LE, Maiyani M, Norton J, Green AR, Sheehan OC, Boyd CM. Central Nervous System Polypharmacy Among People Living With Dementia. J Am Med Dir Assoc. 2025 08; 26(8):105708.
Score: 0.833
-
Bayliss EA, Gleason KS, Sheehan OC, Drace ML, Kraus C, Bedoy R, Martinez AE, Sawyer JK, Norton J, Weffald LA, Green AR, Reeve E, Pieper LE, Maiyani M, Boyd CM. Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trial. Patient Educ Couns. 2026 Jan; 142:109392.
Score: 0.213
-
Dublin S, Albertson-Junkans L, Pham Nguyen TP, Pavon JM, Hastings SN, Maciejewski ML, Willis A, Zepel L, Hennessy S, Albers KB, Mowery D, Clark AG, Thomas S, Steinman MA, Boyd CM, Bayliss EA. Defining key deprescribing measures from electronic health data: A multisite data harmonization project. J Am Geriatr Soc. 2025 02; 73(2):399-410.
Score: 0.201
-
Green AR, Weffald LA, Powers JD, Drace ML, Norton JD, Boyd CM, Bayliss EA. Assessing medication appropriateness as a deprescribing outcome. J Am Geriatr Soc. 2023 12; 71(12):3918-3920.
Score: 0.184
-
Bayliss EA, Albers K, Gleason K, Pieper LE, Boyd CM, Campbell NL, Ensrud KE, Gray SL, Linsky AM, Mangin D, Min L, Rich MW, Steinman MA, Turner J, Vasilevskis EE, Dublin S. Recommendations for outcome measurement for deprescribing intervention studies. J Am Geriatr Soc. 2022 09; 70(9):2487-2497.
Score: 0.169
-
Reeve E, Bayliss EA, Shetterly S, Maiyani M, Gleason KS, Norton JD, Sheehan OC, Green AR, Maciejewski ML, Drace M, Sawyer J, Boyd CM. Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age Ageing. 2023 01 08; 52(1).
Score: 0.044
-
Sheehan OC, Gleason KS, Bayliss EA, Green AR, Drace ML, Norton J, Reeve E, Shetterly SM, Weffald LA, Sawyer JK, Maciejewski ML, Kraus C, Maiyani M, Wolff J, Boyd CM. Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trial. J Am Geriatr Soc. 2023 03; 71(3):774-784.
Score: 0.044
-
Hung A, Sloan CE, Boyd C, Bayliss EA, Hastings SN, Maciejewski ML. Deprescribing medications: Do out-of-pocket costs have a role? J Am Geriatr Soc. 2022 11; 70(11):3334-3337.
Score: 0.043
-
Maciejewski ML, Hammill BG, Bayliss EA, Ding L, Voils CI, Curtis LH, Wang V. Prescriber Continuity and Disease Control of Older Adults. Med Care. 2017 04; 55(4):405-410.
Score: 0.029
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|